This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Karbowniczek M , Zitserman D , Khabibullin D , Hartman T , Yu J , Morrison T , Nicolas E , Squillace R , Roegiers F , Henske EP
The evolutionarily conserved TSC/Rheb pathway activates Notch in tuberous sclerosis complex and Drosophila external sensory organ development
J Clin Invest. 2010 Jan;120(1) :93-102
PMID: 20038815 PMCID: PMC2798691
AbstractMutations in either of the genes encoding the tuberous sclerosis complex (TSC), TSC1 and TSC2, result in a multisystem tumor disorder characterized by lesions with unusual lineage expression patterns. How these unusual cell-fate determination patterns are generated is unclear. We therefore investigated the role of the TSC in the Drosophila external sensory organ (ESO), a classic model of asymmetric cell division. In normal development, the sensory organ precursor cell divides asymmetrically through differential regulation of Notch signaling to produce a pIIa and a pIIb cell. We report here that inactivation of Tsc1 and overexpression of the Ras homolog Rheb each resulted in duplication of the bristle and socket cells, progeny of the pIIa cell, and loss of the neuronal cell, a product of pIIb cell division. Live imaging of ESO development revealed this cell-fate switch occurred at the pIIa-pIIb 2-cell stage. In human angiomyolipomas, benign renal neoplasms often found in tuberous sclerosis patients, we found evidence of Notch receptor cleavage and Notch target gene activation. Further, an angiomyolipoma-derived cell line carrying biallelic TSC2 mutations exhibited TSC2- and Rheb-dependent Notch activation. Finally, inhibition of Notch signaling using a gamma-secretase inhibitor suppressed proliferation of Tsc2-null rat cells in a xenograft model. Together, these data indicate that the TSC and Rheb regulate Notch-dependent cell-fate decision in Drosophila and Notch activity in mammalian cells and that Notch dysregulation may underlie some of the distinctive clinical and pathologic features of TSC.
NotesKarbowniczek, Magdalena Zitserman, Diana Khabibullin, Damir Hartman, Tiffiney Yu, Jane Morrison, Tasha Nicolas, Emmanuelle Squillace, Rachel Roegiers, Fabrice Henske, Elizabeth Petri HL81147/HL/NHLBI NIH HHS/United States R01 DK51052/DK/NIDDK NIH HHS/United States R01 NS059971/NS/NINDS NIH HHS/United States Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States The Journal of clinical investigation J Clin Invest. 2010 Jan;120(1):93-102. doi: 10.1172/JCI40221. Epub 2009 Dec 28.